UBS Maintains a 'Buy' on UnitedHealth Group (UNH); Improved FY’11 Not Enough to Offset High Expectations in S-T

UBS maintains a 'Buy' on UnitedHealth Group (NYSE: UNH), PT increased by $1 to $60.

UBS analyst says, "UNH delivered solid across the board Q2 and took up #’s although high expectations left the stock modestly underperforming for the day. That said, earnings expectations don’t appear as high for Aetna (NYSE: AET) / WellPoint (NYSE: WLP) next week, likely leaving more positive risk reward on any further group weakness. For UNH, we now model FY’11 EPS of $4.40 (vs. prior $4.30, and $0.15 above high end of guid) to reflect Q2 upside/favorable 2H tax rate. We move to $4.80 for 2012 and expect this may prove conservative as we lay out path to $5+ EPS next year."

For more ratings news on UnitedHealth Group click here and for the rating history of UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $51.45 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• United Airlines maintains forecast after Q1 results top Wall Street estimates
• KLA Corporation (KLAC) PT Raised to $760 at Stifel
• Ichor Holdings (ICHR) PT Raised to $45 at Stifel